Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate the long-term safety and efficacy of milnacipran in pediatric patients aged 13 to 17 years with primary fibromyalgia.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Forest Laboratories
Collaborators
Forest Investigative Site 040
Birmingham, Alabama
Forest Investigative Site 033
Bullhead City, Arizona
Forest Investigative Site 012
Fresno, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions